Johann Proeve, Ph.D., strengthens Cyntegrity as CSO

J. Proeve, Ph.D., an expert with 35+ years of experience as Global Data Management Head at Bayer started this week as Chief Scientific Officer at Cyntegrity. Dr_ProeveHe takes the responsibility of building up a proper Risk-based Monitoring (RBM) strategy for each clinical study and develop further Cyntegrity’s core product RBM – EarlyBird.

 

“We welcome Dr. Proeve and believe, as a team, we can bring the RBM concept to new frontiers, make it absolutely essential for patient safety, clinical trials transparency and improved data quality.” (A. Andrianov)

By |2016-11-16T18:35:32+00:00May 24, 2016|News|0 Comments

About the Author:

Professional in the integration of data-driven Risk-based Monitoring (RbM) process in international clinical trials of pharmacology. Speaker at regional and global conferences such as: DIA, PharmaForum, PharmaDay, DGGF, etc. 10+ years of experience in data quality projects and biostatistics for the pharmaceutical industry. Life passion: improving clinical research with RbM, driving the RbM research to new frontiers for CROs, pharma and biotech companies.

Leave A Comment

Upcoming Events

  1. DIA Europe 2019

    February 5, 2019 - February 7, 2019

Register Today!

Get Free Test Access